197 related articles for article (PubMed ID: 21370605)
21. Low-dose escitalopram for 2 days associated with corrected QT interval prolongation in a middle-aged woman: a case report and literature review.
Tseng PT; Lee Y; Lin YE; Lin PY
Gen Hosp Psychiatry; 2012; 34(2):210.e13-5. PubMed ID: 22133983
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of QT interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of QT interval-prolonging drugs: a prospective, observational study in a large urban academic medical center in the US.
Tisdale JE; Wroblewski HA; Overholser BR; Kingery JR; Trujillo TN; Kovacs RJ
Drug Saf; 2012 Jun; 35(6):459-70. PubMed ID: 22612851
[TBL] [Abstract][Full Text] [Related]
23. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
[TBL] [Abstract][Full Text] [Related]
24. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians.
Trinkley KE; Page RL; Lien H; Yamanouye K; Tisdale JE
Curr Med Res Opin; 2013 Dec; 29(12):1719-26. PubMed ID: 24020938
[TBL] [Abstract][Full Text] [Related]
25. QTc prolongation due to propranolol overdose.
Farhangi V; Sansone RA
Int J Psychiatry Med; 2003; 33(2):201-2. PubMed ID: 12968835
[TBL] [Abstract][Full Text] [Related]
26. Population pharmacokinetics and pharmacodynamics of escitalopram in overdose and the effect of activated charcoal.
van Gorp F; Duffull S; Hackett LP; Isbister GK
Br J Clin Pharmacol; 2012 Mar; 73(3):402-10. PubMed ID: 21883384
[TBL] [Abstract][Full Text] [Related]
27. A comparison of the risk of QT prolongation among SSRIs.
Funk KA; Bostwick JR
Ann Pharmacother; 2013 Oct; 47(10):1330-41. PubMed ID: 24259697
[TBL] [Abstract][Full Text] [Related]
28. QTc prolongation and torsades de pointes due to a coadministration of fluoxetine and amiodarone in a patient with implantable cardioverter-defibrillator: Case report and review of the literature.
Wei A; Peng J; Gu Z; Li J
Medicine (Baltimore); 2017 Dec; 96(49):e9071. PubMed ID: 29245320
[TBL] [Abstract][Full Text] [Related]
29. Use of selective serotonin re-uptake inhibitors and the heart rate corrected QT interval in a real-life setting: the population-based Rotterdam Study.
Maljuric NM; Noordam R; Aarts N; Niemeijer MN; van den Berg ME; Hofman A; Kors JA; Stricker BH; Visser LE
Br J Clin Pharmacol; 2015 Oct; 80(4):698-705. PubMed ID: 25966843
[TBL] [Abstract][Full Text] [Related]
30. Torsade de pointes induced by citalopram and amiodarone.
Fayssoil A; Issi J; Guerbaa M; Raynaud JC; Heroguelle V
Ann Cardiol Angeiol (Paris); 2011 Jun; 60(3):165-8. PubMed ID: 21295285
[TBL] [Abstract][Full Text] [Related]
31. Accuracy of a single-lead mobile smartphone electrocardiogram for QT interval measurement in patients undergoing maintenance methadone therapy.
Titus-Lay EN; Jaynes HA; Tomaselli Muensterman E; Ott CA; Walroth TA; Williams G; Moe PR; Wilbrandt M; Tisdale JE
Pharmacotherapy; 2021 Jun; 41(6):494-500. PubMed ID: 33772822
[TBL] [Abstract][Full Text] [Related]
32. In response to van Gorp F. et al. Escitalopram overdose.
Lugassy DM; Hoffman RS; Chessex N
Ann Emerg Med; 2010 Jan; 55(1):128-9; author reply 129-30. PubMed ID: 20116020
[No Abstract] [Full Text] [Related]
33. QTc prolongation, torsades de pointes, and psychotropic medications.
Beach SR; Celano CM; Noseworthy PA; Januzzi JL; Huffman JC
Psychosomatics; 2013; 54(1):1-13. PubMed ID: 23295003
[TBL] [Abstract][Full Text] [Related]
34. QTc abnormalities in deliberate self-poisoning with moclobemide.
Downes MA; Whyte IM; Isbister GK
Intern Med J; 2005 Jul; 35(7):388-91. PubMed ID: 15958107
[TBL] [Abstract][Full Text] [Related]
35. [Citalopram overdose poisoning in QTc interval prolongation].
Ryysy R; Sinisalo J; Viitasalo M
Duodecim; 2006; 122(1):97-102. PubMed ID: 16509195
[No Abstract] [Full Text] [Related]
36. QT interval prolongation and torsades de pointes in a patient undergoing treatment with vorinostat: a case report and review of the literature.
Lynch DR; Washam JB; Newby LK
Cardiol J; 2012; 19(4):434-8. PubMed ID: 22825908
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic-pharmacodynamic modelling of QT interval prolongation following citalopram overdoses.
Friberg LE; Isbister GK; Duffull SB
Br J Clin Pharmacol; 2006 Feb; 61(2):177-90. PubMed ID: 16433872
[TBL] [Abstract][Full Text] [Related]
38. Cardiotoxicity in a citalopram and olanzapine overdose.
Lung DD; Wu AH; Gerona RR
J Emerg Med; 2013 Oct; 45(4):554-8. PubMed ID: 23871479
[TBL] [Abstract][Full Text] [Related]
39. Prolonged QTc interval and torsades de pointes induced by citalopram.
Deshmukh A; Ulveling K; Alla V; Abuissa H; Airey K
Tex Heart Inst J; 2012; 39(1):68-70. PubMed ID: 22412232
[TBL] [Abstract][Full Text] [Related]
40. Emergency department approach to QTc prolongation.
Pourmand A; Mazer-Amirshahi M; Chistov S; Sabha Y; Vukomanovic D; Almulhim M
Am J Emerg Med; 2017 Dec; 35(12):1928-1933. PubMed ID: 28855066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
